CUBIST PHARMACEUTICALS
| WVB Number: 34066NU | Country: United States of America |
| SIC categorization: PHARMACEUTICAL PREPARATIONS (2834) | ISIN: US2296781071 |
| FT categorization: DRUGS (433) |
» Corporation Profile
| Profile in brief: The Company engages in the research, development, and commercialization of products for anti-infective and acute care needs market. |
|
| Phone: 1 781 860 8660 | Fax: 781 861 0566 |
| Chairman: MICHAEL W. BONNEY | Auditor: PRICEWATERHOUSECOOPERS LLP |
| CEO/Managing Director: MICHAEL W. BONNEY | |
» Company Facts
| Net Profit Margin (%) | 16.34 |
| Operating Margin (%) | 20.18 |
| Return on Assets (%) | 9.89 |
| Return on Equity (%) | 69.13 |
| Employees | 489 |
» Company Financials
| Annual (2007) | |
| Income Statement ('000 USD ) |
|
| Sales/Total Revenue | 294,620 |
| EBITDA | 51,107 |
| EBIT | 41,418 |
| Net Income | 48,147 |
| Balance Sheet ( '000 USD) |
|
| Total Current Assets | 409,279 |
| Total Assets | 534,515 |
| Total Current Liabilities | 66,783 |
| Total Liabilities & Debt | 435,813 |
| Total Equity | 98,702 |
| Cash Flow ( '000 USD) |
|
| Net Income/Starting Line | 48,147 |
| Cash from Operating | 80,210 |
| Cash from Investing | -29,136 |
| Cash from Financing | 9,720 |
| Cash & Equivalent Yr End | 354,785 |